N3 hilar sampling decision in the staging of mediastinal lung cancer.

Autor:	Bordas-Martinez J; Pulmonology Dept, Bellvitge University Hospital, UB, IDIBELL, CIBERES, Barcelona, Spain., Vercher-Conejero JL; Nuclear Medicine Dept - PET Unit, Bellvitge University Hospital - IDIBELL, Barcelona, Spain., Rodriguez-González G; Pulmonology Dept, Bellvitge University Hospital, UB, IDIBELL, CIBERES, Barcelona, Spain., Cubero N; Pulmonology Dept, Bellvitge University Hospital, UB, IDIBELL, CIBERES, Barcelona, Spain., Lopez-Lisbona RM; Pulmonology Dept, Bellvitge University Hospital, UB, IDIBELL, CIBERES, Barcelona, Spain., Diez-Ferrer M; Pulmonology Dept, Bellvitge University Hospital, UB, IDIBELL, CIBERES, Barcelona, Spain., Tazi R; Thorax Institute, Germans Trias i Pujol University Hospital, IGTP, UAB, CIBERES, Barcelona, Spain., Rosell A; Thorax Institute, Germans Trias i Pujol University Hospital, IGTP, UAB, CIBERES, Barcelona, Spain.
Jazyk:	angličtina
Zdroj:	ERJ open research [ERJ Open Res] 2021 Aug 23; Vol. 7 (3). Date of Electronic Publication: 2021 Aug 23 (Print Publication: 2021).
DOI:	10.1183/23120541.00116-2021
Abstrakt:	There is insufficient evidence for the sampling of morphometabolically normal N3 hilar lymph nodes https://bit.ly/3gWcar7. Competing Interests: Conflict of interest: J. Bordas-Martinez has nothing to disclose. Conflict of interest: J.L. Vercher-Conejero has nothing to disclose. Conflict of interest: G. Rodriguez-González has nothing to disclose. Conflict of interest: N. Cubero has nothing to disclose. Conflict of interest: R.M. Lopez-Lisbona has nothing to disclose. Conflict of interest: M. Diez-Ferrer has nothing to disclose. Conflict of interest: R. Tazi has nothing to disclose. Conflict of interest: A. Rosell has nothing to disclose. (Copyright ©The authors 2021.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu